Regulatory Affairs Software in Egypt
Pharmaceutical registration software for Egyptian manufacturers and marketing authorisation holders — CTD dossiers, variations, renewals, pricing files and health-authority correspondence in one system, built on RENOVA-RDX from an Egyptian vendor.
One System for the Whole Regulatory Affairs Function
A regulatory affairs manager at an Egyptian pharmaceutical manufacturer or marketing authorisation holder (MAH) is rarely tracking one product. A typical portfolio runs to dozens of registrations, each with its own dossier version, pending variations and an upcoming renewal date. Left to grow on its own, that picture ends up split across a formulation binder, a QC archive and a spreadsheet, reconciled by hand whenever someone asks about status.
Regulatory affairs software exists to stop that reconciliation from being repeated for every product, every year. Its real value shows up at the seams — where a formulation change, a specification update or a document revision made elsewhere in the company has to be reflected in a dossier without anyone re-typing it. CORPEX Informatics, an Egyptian company headquartered in the New Administrative Capital, builds that system as RENOVA-RDX, deployed with Arabic-speaking implementation and support and contracts priced in Egyptian Pounds.
What a Registration Dossier Actually Has to Hold Together
Most health authorities, including Egypt's, register pharmaceutical products against the Common Technical Document (CTD) structure: Module 1 for administrative and region-specific information, Module 2 for summaries, Module 3 for quality data, Module 4 for nonclinical reports, and Module 5 for clinical study reports. Module 1 is never harmonised, so a dossier built for one market is not automatically ready for another. A deeper walkthrough is on the CORPEX blog: CTD dossier structure guide (ICH M4).
Registration is not a one-time event either. A change to formulation, site or specification normally requires a variation filing, and most registrations must be renewed on a fixed cycle. Pricing approvals usually sit inside the Module 1 package. A regulatory affairs system has to hold dossier version, pending variations, renewal deadlines and the last letter from the authority all at once, without depending on memory. That discipline is what regulatory information management (RIM) is built to do.
Why Egyptian Regulatory Teams Choose a Local Vendor
Global regulatory information management platforms are built for multinational headcounts and priced accordingly. Here is where a local partner changes the equation.
Arabic & English
An Arabic-speaking implementation and support team, so officers and reviewers work in the language they draft submissions in day to day.
Egyptian Pound Pricing
Quotes, licensing and support in EGP, scoped to Egyptian manufacturers and MAHs, not per-seat dollar licences sized for global pharma groups.
On-Site in Egypt
On-site configuration, data migration and staff training across Egypt.
One Product Record
Formulation, analysis and stability records a dossier cites live in the same platform R&D and regulatory affairs both work from.
Links to LIMS & eQMS
Certificates of Analysis and change-control records flow in from the QC lab and quality system without re-keying.
A Vendor You Can Visit
A local team in the same time zone, on-site for go-live and renewal season — not a ticket queue abroad.
How RENOVA-RDX Supports Regulatory Affairs
RENOVA-RDX pharmaceutical R&D software connects formulation, analysis and stability records to the Regulatory Affairs module below, so the dossier is compiled from records the system already holds.
Dossier Management & Compilation
Compiles the dossier from formulation, analysis and stability records already on file, with eCTD support readiness built in.
Registration Tracking & Renewal Alerts
Keeps every market's status current and flags renewal deadlines — a lookup, not a search through email.
Correspondence Tracking
Every request, response and commitment to a health authority sits in one record instead of scattered mailboxes.
CTD Files & Product Master Files
Organises CTD files, clinical and bioequivalence study records, approvals, licences, naming and pricing files, scientific files and product master files.
Submissions, Comments & Requests
Tracks submissions and the reviewer comments that come back, so an approval already won speeds up the next filing.
Multi-Market, Multi-Dossier
A scalable system for organisations registering more than one product at a time, each with its own market and status.
Registering Across Egypt and the Wider MENA Region
Egyptian manufacturers exporting into neighbouring markets, and MAHs representing international principals inside Egypt, end up managing several regional dossiers for the same product at once. Each market keeps its own Module 1 package, variation and renewal cycle, and correspondence history, even though Modules 2 through 5 draw on the same underlying data. One scalable system, rather than a folder per country, is what lets an approval already won in one market speed up the next. See the full suite on the regulatory affairs software page, alongside InFlow-PV, CORPEX's pharmacovigilance system for after approval.
What a Reviewer or Auditor Checks, and How the Records Answer It
A reviewer working through a submission, and an internal auditor preparing for an inspection, look for the same consistency: quality data matches the formulation on file, every variation and renewal has a documented trail, and nothing in the correspondence has been left unanswered.
- Formulation-to-dossier traceability. Version-controlled records mean the recipe cited is the one actually analysed and tested.
- Registration status by market. Tracking and renewal alerts turn a status question into a lookup, not a search through email.
- A complete correspondence history. Every request and response sits in one record instead of scattered mailboxes.
- Documents that match the product master file. Licences, naming, pricing and scientific files are held against one product master file, not as loose attachments.
How Regulatory Affairs Connects to the Rest of the CORPEX Platform
A dossier is only as reliable as the records it is built from, and those records live in other CORPEX modules.
QC Data from LIMS
Certificates of Analysis and specification data cited in a dossier originate in the QC lab and its stability studies.
Documents from eQMS
SOPs cited in a submission, and the change controls that trigger a variation filing, live in CORPEX eQMS software in Egypt.
The Full RENOVA-RDX Platform
Regulatory Affairs is one module of RENOVA-RDX regulatory information management software, alongside Formulation, Analysis and Stability.
Implementation and Validation in Egypt
Because RENOVA-RDX holds registration records a health authority relies on, the system has to be validated before it is trusted with a submission. CORPEX delivers computer system validation (CSV) services in Egypt alongside every RENOVA-RDX implementation: a Validation Master Plan, IQ/OQ/PQ execution, and traceability from user requirements through to test evidence, so the platform is inspection-ready at go-live rather than validated after the fact.
Built for Egyptian Drug Authority (EDA) Registration
An EDA registration dossier follows the same CTD logic as any other agency, with Module 1 carrying Egypt-specific administrative documents, labelling and pricing information. Manufacturing sites feeding that dossier are themselves expected to run under EDA GMP, with controlled quality records behind every specification the dossier references. An Egyptian regulatory affairs team tracking several products faces the reconciliation problem described above, multiplied by however many products are on file with the EDA at once.
CORPEX Informatics is an Egyptian company headquartered in the New Administrative Capital. Its regulatory affairs software is deployed with Arabic-speaking support and contracts in Egyptian Pounds. It runs alongside CORPEX eQMS software in Egypt, and is validated on-site through computer system validation services in Egypt — see the full platform on the regulatory information management software page.
Built for Egyptian Pharmaceutical Manufacturers
CORPEX solutions are trusted by leading Egyptian pharmaceutical organisations — including Marcyrl Pharmaceutical Industries, ATCO Pharma, October Pharma, Orchidia Pharmaceutical Industries, and the Egyptian Drug Authority (EDA) itself. That manufacturing footprint is what shapes RENOVA-RDX's Regulatory Affairs module.
Ready to Bring Your Registrations Into One System?
Talk to a local CORPEX specialist about regulatory affairs software configured for your product portfolio, your target markets and your budget — in Arabic or English.
Request a ConsultationRegulatory Affairs Software Egypt — Frequently Asked Questions
What does regulatory affairs software do for an Egyptian pharmaceutical company?
It keeps registration dossiers, variations, renewals, pricing files and correspondence with the health authority in one controlled system instead of a formulation binder, a QC archive and a spreadsheet. CORPEX's regulatory affairs software is RENOVA-RDX, which links dossier compilation and registration tracking to the formulation, analysis and stability records the dossier is built from.
Is there an Egyptian vendor for pharmaceutical registration software?
Yes. CORPEX Informatics is an Egyptian company headquartered in the New Administrative Capital. Its regulatory affairs software, RENOVA-RDX, is deployed with Arabic-speaking support, on-site configuration, and contracts and pricing in Egyptian Pounds, for manufacturers and MAHs across Egypt and the wider MENA region.
What does RENOVA-RDX's Regulatory Affairs module track?
Dossier management and compilation, registration tracking and renewal alerts, and correspondence tracking with authorities, with eCTD support readiness built in. It also organises CTD files, clinical and bioequivalence study records, regulatory approvals, licences, requests, naming and pricing files, scientific files and product master files.
Does RENOVA-RDX handle eCTD publishing or submission to a health authority's electronic gateway?
RENOVA-RDX manages dossier compilation, registration tracking, renewal alerts and correspondence tracking, with eCTD support readiness built in. It does not publish to or submit through a specific health authority's electronic gateway — confirm what your target markets require with your regulatory team.
Can regulatory affairs software connect to our QC lab and quality system?
Yes. RENOVA-RDX is part of the CORPEX platform, so Certificates of Analysis and specification data from CORPEX-LIMS, and SOPs and change records from CORPEX eQMS, connect to the same product record without re-keying — useful since a variation filing is usually triggered by a change control raised elsewhere in the system.
Is RENOVA-RDX validated before it holds registration records?
Yes. RENOVA-RDX implementations are validated through CORPEX's computer system validation (CSV) service — a Validation Master Plan, IQ/OQ/PQ execution and traceability from requirements to test evidence — delivered on-site in Egypt, so the system is inspection-ready at go-live.